- Home
- SLNH vs EVAX Comparison
SLNH vs EVAX Comparison
Compare SLNH & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNH
- EVAX
- Stock Information
- Founded
- SLNH 1961
- EVAX 2008
- Country
- SLNH United States
- EVAX Denmark
- Employees
- SLNH N/A
- EVAX N/A
- Industry
- SLNH EDP Services
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SLNH Technology
- EVAX Health Care
- Exchange
- SLNH Nasdaq
- EVAX Nasdaq
- Market Cap
- SLNH 15.5M
- EVAX 17.8M
- IPO Year
- SLNH N/A
- EVAX 2021
- Fundamental
- Price
- SLNH $2.91
- EVAX $6.48
- Analyst Decision
- SLNH Hold
- EVAX Strong Buy
- Analyst Count
- SLNH 1
- EVAX 2
- Target Price
- SLNH N/A
- EVAX $13.50
- AVG Volume (30 Days)
- SLNH 16.7M
- EVAX 894.4K
- Earning Date
- SLNH 11-13-2025
- EVAX 11-07-2025
- Dividend Yield
- SLNH N/A
- EVAX N/A
- EPS Growth
- SLNH N/A
- EVAX N/A
- EPS
- SLNH N/A
- EVAX N/A
- Revenue
- SLNH $27,891,000.00
- EVAX $3,176,000.00
- Revenue This Year
- SLNH N/A
- EVAX $129.34
- Revenue Next Year
- SLNH $42.68
- EVAX N/A
- P/E Ratio
- SLNH N/A
- EVAX N/A
- Revenue Growth
- SLNH N/A
- EVAX 1042.45
- 52 Week Low
- SLNH $0.36
- EVAX $1.20
- 52 Week High
- SLNH $5.14
- EVAX $15.50
- Technical
- Relative Strength Index (RSI)
- SLNH 51.88
- EVAX 53.61
- Support Level
- SLNH $2.93
- EVAX $5.29
- Resistance Level
- SLNH $3.84
- EVAX $12.15
- Average True Range (ATR)
- SLNH 0.77
- EVAX 1.25
- MACD
- SLNH -0.12
- EVAX -0.26
- Stochastic Oscillator
- SLNH 27.57
- EVAX 17.35
About SLNH Soluna Holdings Inc.
Soluna Holdings Inc is a U.S.-based company that conducts operations through its subsidiary. The group is engaged in the mining of cryptocurrency through data centers that can be powered by renewable energy sources. The data centers buy every excess megawatt to use for batch-oriented, computing-intensive processes such as cryptocurrency mining or machine learning which is a low-risk and low-friction solution to use as a smartphone.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.